Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Appel

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The American Journal of the Medical Sciences|May 17, 2007
Monoclonal gammopathy presenting as recurrent nephrotic syndrome: therapeutic implicationsSrivilliputtur G Santhana Krishnan, Elsa Valderrama, John D Wagner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trialGershon Frisch, Julie Lin, Jordan Rosenstock, et al.
Arthritis and Rheumatism|January 11, 2012
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab studyBrad H Rovin, Richard Furie, Kevin Latinis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 26, 2015
Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathyRonald J Hogg, R Curtis Bay, J Charles Jennette, et al.
Kidney International|December 8, 2022
Glomerular diseases in pregnancy: pragmatic recommendations for clinical managementFadi Fakhouri, Nora Schwotzer, Gianfranca Cabiddu, et al.
Clinical Kidney Journal|September 9, 2020
The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the Nephrotic Syndrome Study NetworkJonathan P Troost, Anne Waldo, Noelle E Carlozzi, et al.
Pediatric Nephrology (Berlin, Germany)|March 1, 2021
APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosisJarcy Zee, Michelle T McNulty, Jeffrey B Hodgin, et al.
Nature Genetics|October 13, 2014
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogensKrzysztof Kiryluk, Yifu Li, Francesco Scolari, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The American Journal of the Medical Sciences|May 17, 2007
Monoclonal gammopathy presenting as recurrent nephrotic syndrome: therapeutic implicationsSrivilliputtur G Santhana Krishnan, Elsa Valderrama, John D Wagner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trialGershon Frisch, Julie Lin, Jordan Rosenstock, et al.
Arthritis and Rheumatism|January 11, 2012
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab studyBrad H Rovin, Richard Furie, Kevin Latinis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 26, 2015
Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathyRonald J Hogg, R Curtis Bay, J Charles Jennette, et al.
Kidney International|December 8, 2022
Glomerular diseases in pregnancy: pragmatic recommendations for clinical managementFadi Fakhouri, Nora Schwotzer, Gianfranca Cabiddu, et al.
Clinical Kidney Journal|September 9, 2020
The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the Nephrotic Syndrome Study NetworkJonathan P Troost, Anne Waldo, Noelle E Carlozzi, et al.
Pediatric Nephrology (Berlin, Germany)|March 1, 2021
APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosisJarcy Zee, Michelle T McNulty, Jeffrey B Hodgin, et al.
Nature Genetics|October 13, 2014
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogensKrzysztof Kiryluk, Yifu Li, Francesco Scolari, et al.
Pageof 2